Toraji Amano

Sapporo, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 34 publications

Actionable Gene Alterations Identified in Patients With Malignant Melanoma by Targeted Sequencing in Japan.

Actionable Gene Alterations Identified in Patients With Malignant Melanoma by Targeted Sequencing in Japan.

Journal: JCO precision oncology

Published: January 17, 2025

Non-small cell lung cancer with synchronous brain metastases: Identification of prognostic factors in a retrospective multicenter study (HOT 1701).

Non-small cell lung cancer with synchronous brain metastases: Identification of prognostic factors in a retrospective multicenter study (HOT 1701).

Journal: Neuro-oncology advances

Published: November 14, 2024

A Learning Program for Treatment Recommendations by Molecular Tumor Boards and Artificial Intelligence.

A Learning Program for Treatment Recommendations by Molecular Tumor Boards and Artificial Intelligence.

Journal: JAMA oncology

Published: November 30, 2023

Assessment for the timing of comprehensive genomic profiling tests in patients with advanced solid cancers.

Assessment for the timing of comprehensive genomic profiling tests in patients with advanced solid cancers.

Journal: Cancer science

Published: January 04, 2023

Concordance Between Recommendations From Multidisciplinary Molecular Tumor Boards and Central Consensus for Cancer Treatment in Japan.

Concordance Between Recommendations From Multidisciplinary Molecular Tumor Boards and Central Consensus for Cancer Treatment in Japan.

Journal: JAMA network open

Published: December 05, 2022

Germline PRDM1 Variant rs2185379 in Long-Term Recurrence-Free Survivors of Advanced Ovarian Cancer.

Germline PRDM1 Variant rs2185379 in Long-Term Recurrence-Free Survivors of Advanced Ovarian Cancer.

Journal: Pharmacogenomics and personalized medicine

Published: August 25, 2022

Expert panel consensus recommendations on the use of circulating tumor DNA assays for patients with advanced solid tumors.

Expert panel consensus recommendations on the use of circulating tumor DNA assays for patients with advanced solid tumors.

Journal: Cancer science

Published: May 27, 2022

First-in-human phase 1 trial of hemoglobin vesicles as artificial red blood cells developed for use as a transfusion alternative.

First-in-human phase 1 trial of hemoglobin vesicles as artificial red blood cells developed for use as a transfusion alternative.

Journal: Blood advances

Published: April 29, 2022

Chronological improvement in precision oncology implementation in Japan.

Chronological improvement in precision oncology implementation in Japan.

Journal: Cancer science

Published: March 11, 2022

Prognostic significance of OX40+ lymphocytes in tumor stroma of surgically resected small-cell lung cancer.

Prognostic significance of OX40+ lymphocytes in tumor stroma of surgically resected small-cell lung cancer.

Journal: Oncoimmunology

Published: September 23, 2021

Development of a System for Providing Cancer Genomic Medicine in Hokkaido-From the Standpoint of a Designated Core Hospital for Cancer Genomic Medicine

Development of a System for Providing Cancer Genomic Medicine in Hokkaido-From the Standpoint of a Designated Core Hospital for Cancer Genomic Medicine

Journal: Gan to kagaku ryoho. Cancer & chemotherapy

Published: July 16, 2021

Genetic heterogeneity during breast cancer progression in young patients.

Genetic heterogeneity during breast cancer progression in young patients.

Journal: Breast (Edinburgh, Scotland)

Published: May 13, 2021

Showing 1-12 of 34

Last Updated: 09/26/2026